Cancer Drug Parity Act of 2025

House Bill

H.R. 4101

119th Congress

Cancer Drug Parity Act of 2025

In Committee

Introduced:Jun 25, 2025

Primary Sponsor

Glenn Grothman

Representative

Republican

WI-6

Cosponsors

2

Quick Stats

Policy Area

Health

Summary

This bill reauthorizes funding for a program that provides training and technical assistance to peer-run addiction recovery support services. These services help people in recovery access resources and build community as they work to maintain sobriety.

Latest Action

Referred to the Subcommittee on Health.

SponsorGlenn Grothman (R-WI)

Introduced6/25/2025

StatusReferred to the House Committee on Education and Workforce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Cancer Drug Parity Act of 2025

This bill reauthorizes funding for a program that provides training and technical assistance to peer-run addiction recovery support services. These services help people in recovery access resources and build community as they work to maintain sobriety.

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill reauthorizes funding for a program that provides training and technical assistance to peer-run addiction recovery support services. These services help people in recovery access resources and build community as they work to maintain sobriety.

Bill Number: 4101
Sponsor: Glenn Grothman (R-WI)
Introduced: 6/25/2025
Status: Referred to the House Committee on Education and Workforce.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Cancer Drug Parity Act of 2025
Bill Number: 4101
Sponsor: Glenn Grothman (R-WI)
Status: Referred to the House Committee on Education and Workforce.
Introduced: 6/25/2025
Summary: This bill reauthorizes funding for a program that provides training and technical assistance to peer-run addiction recovery support services. These services help people in recovery access resources and build community as they work to maintain sobriety.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill reauthorizes funding for a program that provides training and technical assistance to peer-run addiction recovery support services. These services help people in recovery access resources and build community as they work to maintain sobriety.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

Road To Recovery Act This bill reauthorizes through FY2028 the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support, which is administered by the Substance Abuse and Mental Health Services Administration.

Key Points

Main provisions of the bill

Reauthorizes funding for a National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support through 2028.
The center provides training and support to peer-run organizations that offer addiction recovery services and resources.
Peer-run services help people in recovery build community, access resources, and maintain sobriety.

How This Impacts Americans

Potential effects on citizens and communities

This bill would help sustain and strengthen peer-run addiction recovery support services across the country. People in recovery, as well as their families and communities, would benefit from the continued availability of these critical services that aid the recovery process.

Policy Areas

Primary Policy Area

Health

Related Subjects

Community life and organization

Drug, alcohol, tobacco use

Health programs administration and funding

Mental health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

4101, 119th Congress (2025). "Cancer Drug Parity Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-4101

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.